Pediatric Vaccines Market Size, Share Analysis and Report 2024-2031

Pediatric Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Pediatric Vaccines Market&nbsp;Size, Share &amp; Trends Analysis Report By Disease Type, By Vaccine Type, By Technology, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Pediatric Vaccines market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Vaccinations specifically designed for pediatric patients are essential for shielding young patients from a variety of potentially dangerous illnesses. These vaccinations aid in a child&#39;s body&#39;s development of immunity against particular illnesses. A child&#39;s body is ready to combat the virus or bacterium when they are exposed to it later in life.&nbsp;

Pediatric vaccines include Diphtheria, tetanus, and whooping cough (pertussis) (DTaP) Haemophilus influenzae type b (Hib) Measles, mumps, rubella (MMR) Polio (IPV) among others.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Disease Type, Vaccine Type, Technology
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

<h2>&nbsp;</h2>

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/pediatric-vaccines-market" target="_blank">Request for Sample</a>

<h2>&nbsp;</h2>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Rising incidence of chronic and infectious diseases

The rising incidence of chronic and infectious diseases is a significant driver for the growth of the global pediatric vaccine market. Rising infections create an awareness and concern among individuals to control these infections. This increases demand for pediatrics vaccinations to avoid infections for the rest of their lives.&nbsp;

There is an increased infection rate among individuals who are suffering from infections. For instance according to the World Health Organization in 2024, it was reported that in 2022, there were an estimated 1,36,000 measles deaths globally, mostly among unvaccinated or under-vaccinated children under the age of 5 years. This creates an awareness among unvaccinated individuals.

Additionally, the National Foundation for Infectious Diseases stated that Influenza (flu) is a serious illness that leads to thousands of hospitalizations, most in children younger than 5 years of age. It is estimated that an average of 20,000 children under the age of 5 are hospitalized due to flu complications each year. Thus, the above factors are expected to drive the market growth.

Limited availability of healthcare services&nbsp;

Access to immunization&nbsp;clinics and healthcare professionals qualified to deliver vaccines might be challenging in rural or isolated locations with inadequate healthcare infrastructure. Children in such areas may have experienced decreased immunization&nbsp;rates as a result. Vaccine delivery programs&nbsp;may encounter difficulties due to a shortage of medical professionals with the necessary training, such as nurses and doctors, to provide immunizations because of which immunization&nbsp;schedules for children may be delayed or disrupted.

<h3>Segment Analysis</h3>

The global pediatric vaccine market is segmented based on disease type, vaccine type, technology and region.

Multivalent Vaccines segment is expected to dominate the market growth

Broader-spectrum multivalent vaccinations have the potential to enhance herd immunity, hence reducing disease transmission and outbreaks in communities. In a single dose, multivalent vaccinations protect against several diseases. As a result, a child requires fewer injections overall, which lessens the pain and worry related to vaccines. This raises vaccine completion rates and adherence to immunization schedules.&nbsp;

They offer defense against a greater variety of disease-causing strains or serotypes. This is especially important for illnesses like influenza when new strains appear all the time. For instance, compared to a monovalent vaccine, the hexavalent vaccine provides more extensive immunity by protecting against six distinct rotavirus strains. It may be less expensive to use a multivalent vaccine than to give several monovalent doses. Parents and healthcare systems can both save money as a result of this.&nbsp;&nbsp;

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the pediatric vaccine market share 

North America accounted for the largest revenue share in 2023. North America has a well-established and innovative pharmaceutical industry that heavily invests in research and development of new and improved vaccines, including pediatric options. Public health initiatives that support childhood immunization are well-established in many North American nations. This implies that there is a wider market for pediatric vaccines to target.

The presence of a large number of major market players in the region is also expected to contribute to the growth of the market in the region. Pharmaceutical companies are manufacturing a variety of vaccinations that increase the availability to children in every remote area.&nbsp;

For instance, on April 27, 2023, Pfizer Inc. received the U.S. Food and Drug Administration (FDA) approval for PREVNAR 20 (20-valent Pneumococcal Conjugate Vaccine) for the prevention of invasive pneumococcal disease (IPD) caused by the 20 Streptococcus pneumoniae (pneumococcal) serotypes contained in the vaccine in infants and children six weeks through 17 years of age, and for the prevention of otitis media in infants six weeks through five years of age caused by the original seven serotypes contained in PREVNAR.

Additionally, in August 2023, Pfizer Inc. received the U.S. Food and Drug Administration (FDA) approval for the ABRYSVO (Respiratory Syncytial Virus Vaccine), the company&rsquo;s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of LRTD and severe LRTD caused by RSV in infants from birth up to six months of age by active immunization of pregnant individuals at 32 through 36 weeks gestational age. Thus, the above factors are expected to hold the region in the dominant market share during the forecast period.&nbsp;

<h3>COVID-19 Impact Analysis</h3>

COVID-19 has shown a negative impact on the pediatric vaccine market growth. Regular pediatric&nbsp;vaccines were delayed as a result of lockdowns and worries about COVID-19 contamination. Some pediatric&nbsp;vaccines experienced a decrease in demand as a result of this. False information about COVID-19 immunizations has&nbsp;made people more reluctant to get immunized&nbsp;overall, including children. Routine childhood vaccinations may have been delayed as a result of the pandemic response&#39;s overwhelming strain on healthcare services.

<h3>Market Segmentation</h3>

By Disease Type

<ul>
	<li>Infectious Diseases&nbsp;
	<ul>
		<li>Polio</li>
		<li>Influenza</li>
		<li>Measles</li>
		<li>Mumps&nbsp;&nbsp;</li>
		<li>Rubella (MMR)</li>
		<li>Pneumococcal disease</li>
		<li>Human papillomavirus</li>
		<li>Hepatitis</li>
		<li>Others</li>
	</ul>
	</li>
	<li>Allergies&nbsp;</li>
</ul>

By Vaccine Type

<ul>
	<li>Monovalent Vaccines</li>
	<li>Multivalent Vaccines</li>
</ul>

By Technology

<ul>
	<li>Live attenuated Vaccines</li>
	<li>Inactivated Vaccines</li>
	<li>Sub-unit Vaccines</li>
	<li>Toxoid Vaccines</li>
	<li>Conjugate Vaccines</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>South Korea</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa&nbsp;&nbsp;</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include Pfizer Inc., Sanofi SA, Merck &amp; Co., Takeda Pharmaceuticals, Indian Immunological limited, Bharat Biotech, Panacea Biotec, Sinovac Biotech, AstraZeneca, and Novartis AG among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global pediatric vaccines market segmentation based on disease type, vaccine type, technology and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of pediatric vaccines market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global pediatric vaccines market report would provide approximately 53 tables, 47 figures and 176 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Type</li>
		<li>Snippet by Application</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising incidence of chronic and infectious diseases</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Limited availability of healthcare services&nbsp;</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>Infectious Diseases*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
			<li>Polio</li>
			<li>Influenza</li>
			<li>Measles</li>
			<li>Mumps&nbsp;&nbsp;</li>
			<li>Rubella (MMR)</li>
			<li>Pneumococcal disease</li>
			<li>Human papillomavirus</li>
			<li>Hepatitis</li>
			<li>Others</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Allergies</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Vaccine Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
			<li>Market Attractiveness Index, By Vaccine Type</li>
		</ol>
		</li>
		<li>Monovalent Vaccines *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Multivalent Vaccines</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>Live attenuated Vaccines*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Inactivated Vaccines</li>
		<li>Sub-unit Vaccines</li>
		<li>Toxoid Vaccines</li>
		<li>Conjugate Vaccines</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			</ol>
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Pfizer Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Sanofi SA</li>
		<li>Merck &amp; Co.&nbsp;</li>
		<li>Takeda Pharmaceuticals</li>
		<li>Indian Immunological limited</li>
		<li>Bharat Biotech</li>
		<li>Panacea Biotec</li>
		<li>Sinovac Biotech</li>
		<li>AstraZeneca</li>
		<li>Novartis AG&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Pediatric Vaccines Market Value, By Disease Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Pediatric Vaccines Market Value, By Vaccine Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Pediatric Vaccines Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Pediatric Vaccines Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Pediatric Vaccines Market Value, By Disease Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 7 Global Pediatric Vaccines Market Value, By Vaccine Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 9 Global Pediatric Vaccines Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 11 Global Pediatric Vaccines Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Pediatric Vaccines Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 14 North America Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 15 North America Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 16 North America Pediatric Vaccines Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 18 South America Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 19 South America Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 20 South America Pediatric Vaccines Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 22 Europe Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 23 Europe Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 24 Europe Pediatric Vaccines Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Pediatric Vaccines Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East &amp; Africa Pediatric Vaccines Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 30 Middle East &amp; Africa Pediatric Vaccines Market Value, By Vaccine Type, 2022-2031 (US$ Million)

Table 31 Middle East &amp; Africa Pediatric Vaccines Market Value, By Technology, 2022-2031 (US$ Million)

Table 32 Pfizer Inc. : Overview

Table 33 Pfizer Inc. : Product Portfolio

Table 34 Pfizer Inc. : Key Developments

Table 35 Sanofi SA: Overview

Table 36 Sanofi SA: Product Portfolio

Table 37 Sanofi SA: Key Developments

Table 38 Merck &amp; Co. : Overview

Table 39 Merck &amp; Co. : Product Portfolio

Table 40 Merck &amp; Co. : Key Developments

Table 41 Takeda Pharmaceuticals: Overview

Table 42 Takeda Pharmaceuticals: Product Portfolio

Table 43 Takeda Pharmaceuticals: Key Developments

Table 44 Indian Immunological limited: Overview

Table 45 Indian Immunological limited: Product Portfolio

Table 46 Indian Immunological limited: Key Developments

Table 47 Bharat Biotech: Overview

Table 48 Bharat Biotech: Product Portfolio

Table 49 Bharat Biotech: Key Developments

Table 50 Panacea Biotec: Overview

Table 51 Panacea Biotec: Product Portfolio

Table 52 Panacea Biotec: Key Developments

Table 53 Sinovac Biotech: Overview

Table 54 Sinovac Biotech: Product Portfolio

Table 55 Sinovac Biotech: Key Developments

Table 56 AstraZeneca: Overview

Table 57 AstraZeneca: Product Portfolio

Table 58 AstraZeneca: Key Developments

Table 59 Novartis AG: Overview

Table 60 Novartis AG: Product Portfolio

Table 61 Novartis AG: Key Developments

List of Figures

Figure 1 Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 2 Global Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 3 Global Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 4 Global Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 5 Global Pediatric Vaccines Market Share, By Region, 2023 &amp; 2031 (%)

Figure 6 Global Pediatric Vaccines Market Y-o-Y Growth, By Disease Type, 2023-2031 (%)

Figure 7 Infectious Diseases Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 8 Allergies Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 9 Global Pediatric Vaccines Market Y-o-Y Growth, By Vaccine Type, 2023-2031 (%)

Figure 10 Monovalent Vaccines Vaccine Type in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 11 Multivalent Vaccines Vaccine Type in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 12 Global Pediatric Vaccines Market Y-o-Y Growth, By Technology, 2023-2031 (%)

Figure 13 Live attenuated Vaccines Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 14 Inactivated Vaccines Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 15 Sub-unit Vaccines Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 16 Toxoid Vaccines Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 17 Conjugate Vaccines Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 18 Others Technology in Global Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 19 Global Pediatric Vaccines Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 20 North America Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 21 Asia-Pacific Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 22 Europe Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 23 South America Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 24 Middle East and Africa Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 25 North America Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 26 North America Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 27 North America Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 28 North America Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 29 North America Pediatric Vaccines Market Share, By Country, 2023 &amp; 2031 (%)

Figure 30 South America Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 31 South America Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 32 South America Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 33 South America Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 34 South America Pediatric Vaccines Market Share, By Country, 2023 &amp; 2031 (%)

Figure 35 Europe Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 36 Europe Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 37 Europe Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 38 Europe Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 39 Europe Pediatric Vaccines Market Share, By Country, 2023 &amp; 2031 (%)

Figure 40 Asia-Pacific Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 41 Asia-Pacific Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 42 Asia-Pacific Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 43 Asia-Pacific Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 44 Asia-Pacific Pediatric Vaccines Market Share, By Country, 2023 &amp; 2031 (%)

Figure 45 Middle East &amp; Africa Pediatric Vaccines Market Value, 2022-2031 (US$ Million)

Figure 46 Middle East &amp; Africa Pediatric Vaccines Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 47 Middle East &amp; Africa Pediatric Vaccines Market Share, By Vaccine Type, 2023 &amp; 2031 (%)

Figure 48 Middle East &amp; Africa Pediatric Vaccines Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 49 Pfizer Inc. : Financials

Figure 50 Sanofi SA: Financials

Figure 51 Merck &amp; Co. : Financials

Figure 52 Takeda Pharmaceuticals: Financials

Figure 53 Indian Immunological limited: Financials

Figure 54 Bharat Biotech: Financials

Figure 55 Panacea Biotec: Financials

Figure 56 Sinovac Biotech: Financials

Figure 57 AstraZeneca: Financials

Figure 58 Novartis AG: Financials

Pediatric Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

Influenza Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17

Starting from

Shingles Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 21

Starting from

Combination Vaccines Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 11

Starting from